Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OATH-AMI: Optimized Antithrombotic Therapy for AMI with LV Mural Thrombus
NCT03415386Phase 4Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clopidogrel, ticagrelor, warfarin, dabigatran in acute myocardial infarction (AMI), left ventricular thrombus (LVT), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
clopidogrelticagrelorwarfarindabigatran
03
Conditions
acute myocardial infarction (AMI)left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT03415386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415386.